HPV Vaccines Market Research Report 2019 ď ľ
Published On : 4 April 2019
E-mail: help@grandresearchstore.com
Report Studies Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection. HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners.
E-mail: help@grandresearchstore.com
By Manufacture
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer E-mail: help@grandresearchstore.com
HPV Vaccines Market By Application 6 5 4 3 2 1 0
Application1
Application2 2018
Application3 2025
Application4
growth
E-mail: help@grandresearchstore.com
HPV Vaccines Market Value
CAGR 41.8% (2018 - 2023)
xx
2018
xx
2019
xx
2020
xx
2021
xx
2022
xx
2023
xx
2024
xx
2025
E-mail: help@grandresearchstore.com
Get in touch
+91 8087042414 (Asia)
+1 (646) 781 7170 (International)
www.grandresearchstore.com
help@grandresearchstore.com
Click here to know mor e about report
Follow us: